Abstract
Oncologic emergencies encompass a variety of clinical entities including tumor lysis syndrome (TLS), superior vena cava syndrome, neutropenic fever, and symptomatic leukostasis (SL). This chapter provides a detailed discussion on the prevention, diagnosis, treatment, and prognosis of oncologic emergencies. TLS is most commonly associated with hematologic malignancies. The best treatment for TLS is prevention, employing continuous cardiac monitoring, serial laboratory evaluations (electrolytes, renal function, uric acid) every 4–6 hours, and rasburicase 0.2 mg/kg with repeated dosing as needed in high risk patients. SL occurs in the setting of hyperleukocytosis, commonly seen in patients with acute myeloid leukemia or chronic myeloid leukemia in blast crisis, in which leukocyte plugs in the microvasculature decrease tissue perfusion.
| Original language | English |
|---|---|
| Title of host publication | Mount Sinai Expert Guides |
| Subtitle of host publication | Critical Care |
| Publisher | wiley |
| Pages | 586-595 |
| Number of pages | 10 |
| ISBN (Electronic) | 9781119293255 |
| ISBN (Print) | 9781119293262 |
| DOIs | |
| State | Published - 1 Jan 2020 |
Keywords
- Hematologic malignancies
- Neutropenic fever
- Oncologic emergencies
- Superior vena cava syndrome
- Symptomatic leukostasis
- Tumor lysis syndrome